MediPharm Labs Corp. (LABS.TO)

CAD 0.06

(-7.69%)

Total Debt Summary of MediPharm Labs Corp.

MediPharm Labs Corp.'s latest annual total debt in 2023 was 2.29 Million CAD , up 263.13% from previous year.
MediPharm Labs Corp.'s latest quarterly total debt in 2024 Q2 was 2.81 Million CAD , up 32.86% from previous quarter.
MediPharm Labs Corp. reported annual total debt of 632 Thousand CAD in 2022, up 192.59% from previous year.
MediPharm Labs Corp. reported annual total debt of 216 Thousand CAD in 2021, down -98.83% from previous year.
MediPharm Labs Corp. reported quarterly total debt of 2.81 Million CAD for 2024 Q2, up 32.86% from previous quarter.
MediPharm Labs Corp. reported quarterly total debt of 2.29 Million CAD for 2023 Q4, down -15.63% from previous quarter.

Annual Total Debt Chart of MediPharm Labs Corp. (2023 - 2016)

Historical Annual Total Debt of MediPharm Labs Corp. (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	2.29 Million CAD	263.13%
2022	632 Thousand CAD	192.59%
2021	216 Thousand CAD	-98.83%
2020	18.45 Million CAD	74.46%
2019	10.58 Million CAD	76.33%
2018	6 Million CAD	394.64%
2017	1.21 Million CAD	4778.93%
2016	24.86 Thousand CAD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	2.11 Million CAD	-7.84%
2024 Q2	2.81 Million CAD	32.86%
2023 Q4	2.29 Million CAD	-15.63%
2023 FY	2.29 Million CAD	263.13%
2023 Q2	2.91 Million CAD	1235.78%
2023 Q1	218 Thousand CAD	-65.51%
2023 Q3	2.72 Million CAD	-6.59%
2022 Q2	1.44 Million CAD	825.64%
2022 Q4	632 Thousand CAD	-45.94%
2022 FY	632 Thousand CAD	192.59%
2022 Q1	156 Thousand CAD	-27.78%
2022 Q3	1.16 Million CAD	-19.04%
2021 Q1	3.54 Million CAD	-80.78%
2021 FY	216 Thousand CAD	-98.83%
2021 Q4	216 Thousand CAD	-90.42%
2021 Q3	2.25 Million CAD	7.44%
2021 Q2	2.09 Million CAD	-40.87%
2020 FY	18.45 Million CAD	74.46%
2020 Q1	10.25 Million CAD	-3.05%
2020 Q2	16.28 Million CAD	58.81%
2020 Q3	31.38 Million CAD	92.69%
2020 Q4	18.45 Million CAD	-41.19%
2019 Q2	6 Million CAD	0.0%
2019 FY	10.58 Million CAD	76.33%
2019 Q4	10.58 Million CAD	54.57%
2019 Q3	6.84 Million CAD	14.08%
2019 Q1	6 Million CAD	0.0%
2018 Q3	1.99 Million CAD	6.71%
2018 FY	6 Million CAD	394.64%
2018 Q1	- CAD	-100.0%
2018 Q2	1.87 Million CAD	0.0%
2018 Q4	6 Million CAD	200.51%
2017 FY	1.21 Million CAD	4778.93%
2017 Q4	1.21 Million CAD	0.0%
2017 Q3	- CAD	0.0%
2017 Q1	- CAD	0.0%
2016 FY	24.86 Thousand CAD	0.0%

Peer Total Debt Comparison of MediPharm Labs Corp.

Name	Total Debt	Total Debt Difference
Aurora Cannabis Inc.	104.79 Million CAD	97.81%
Avicanna Inc.	1.8 Million CAD	-27.26%
Avant Brands Inc.	18.7 Million CAD	87.729%
Cardiol Therapeutics Inc.	158.53 Thousand CAD	-1347.657%
Crescita Therapeutics Inc.	1.25 Million CAD	-83.014%
Knight Therapeutics Inc.	69.09 Million CAD	96.678%
OrganiGram Holdings Inc.	155 Thousand CAD	-1380.645%
Canopy Growth Corporation	683.17 Million CAD	99.664%
Willow Biosciences Inc.	2.15 Million CAD	-6.447%
Auxly Cannabis Group Inc.	159.04 Million CAD	98.557%